Torald Sollmann Award in Pharmacology

Torald Sollmann Award in Pharmacology. It is a distinguished mid-career award presented by the American Society for Pharmacology and Experimental Therapeutics (ASPET) to recognize outstanding original research contributions to pharmacology. The award honors the legacy of Torald Sollmann, a foundational figure in American pharmacology and a former president of the American Society for Pharmacology and Experimental Therapeutics. It is considered one of the most prestigious accolades for pharmacologists in the United States, celebrating sustained excellence in experimental therapeutics and drug discovery.

History and establishment

The award was established in 1961 through an endowment from the Sandoz corporation, now part of Novartis, to commemorate the significant contributions of Torald Sollmann. Sollmann was a pioneering pharmacologist, longtime editor of the journal Pharmacology and Experimental Therapeutics, and a key architect of the Pure Food and Drug Act of 1906. His work at Western Reserve University, now Case Western Reserve University, helped establish rigorous standards in drug testing and toxicology. The creation of the award coincided with a period of rapid expansion in the pharmaceutical industry and academic pharmacology following milestones like the development of penicillin and the thalidomide tragedy. It was designed to encourage and highlight the type of rigorous, integrative research that Sollmann championed throughout his career at institutions like the University of Pennsylvania and the American Medical Association.

Award criteria and nomination process

The award is specifically intended for investigators who are in the mid-career stage, typically 15 to 25 years after earning their terminal degree, such as an M.D. or Ph.D.. Candidates must be members of the American Society for Pharmacology and Experimental Therapeutics and are evaluated primarily on the originality, significance, and impact of their research in experimental pharmacology. The nomination process involves submission of a detailed dossier including a curriculum vitae, a list of publications in journals like Molecular Pharmacology or Clinical Pharmacology & Therapeutics, and letters of support from recognized leaders in the field. A selection committee appointed by the American Society for Pharmacology and Experimental Therapeutics Council reviews all nominations, with the final decision emphasizing a sustained record of independent contributions that advance understanding in areas such as neuropharmacology, cardiovascular pharmacology, or chemotherapy.

Recipients and notable contributions

Since its inception, the award has been granted to many luminaries who have shaped modern pharmacology. Early recipients include Louis S. Goodman, co-author of the seminal textbook Goodman and Gilman's The Pharmacological Basis of Therapeutics, and Avram Goldstein, founder of the Addiction Research Foundation. Later awardees have made groundbreaking discoveries in G protein-coupled receptor signaling, ion channel physiology, and pharmacogenomics. Notable recipients such as Robert J. Lefkowitz, a recipient of the Nobel Prize in Chemistry, and Solomon H. Snyder, a pioneer in neurotransmitter research, exemplify the award's focus on transformative science. Their work, often published in Science and Nature, has led to new drug classes for conditions ranging from hypertension to psychiatric disorders.

Significance and impact in pharmacology

The Torald Sollmann Award serves as a major career milestone and recognition of a pharmacologist's influence on both basic science and therapeutic application. It highlights research that bridges the gap between molecular mechanisms and clinical medicine, fostering innovation in drug development. The award's association with the American Society for Pharmacology and Experimental Therapeutics and its annual meeting at venues like the Experimental Biology conference amplifies the recipient's visibility within the global scientific community. By honoring mid-career scientists, it provides critical encouragement and resources that often propel further pioneering work, influencing grant funding from agencies like the National Institutes of Health and shaping research directions at institutions from Stanford University to the National Institute of Mental Health.

Administration and sponsoring organization

The award is wholly administered by the American Society for Pharmacology and Experimental Therapeutics, a professional society founded in 1908 at a meeting in Baltimore. ASPET oversees the award's endowment, manages the selection committee, and presents the award during its annual scientific sessions. The society, which also sponsors other major awards like the Goodman and Gilman Award in Drug Receptor Pharmacology, is dedicated to advancing the science of pharmacology and its application to human health. Financial stewardship of the award fund ensures the prize includes a monetary component, an engraved plaque, and support for the recipient to deliver a named lecture, thereby perpetuating the educational mission championed by Torald Sollmann and the founding members of ASPET.

Category:American Society for Pharmacology and Experimental Therapeutics Category:Medical and health awards Category:Pharmacology awards